Stepan VP Robin Weitkamp discloses equity holdings
Stepan Company executive Robin Joseph Weitkamp, VP and GM Surfactants-INT, filed an initial ownership report showing various equity-based awards.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
3
Rhea-AI Filing Summary
Stepan Company executive Robin Joseph Weitkamp, VP and GM Surfactants-INT, filed an initial ownership report showing various equity-based awards. The filing lists restricted stock units, stock appreciation rights and performance shares that each represent contingent rights to receive Stepan common stock, subject to time-based vesting and performance goals. It also notes an indirect holding of 96.9 shares of common stock through an ESOP II Trust.
Insider Trade Summary
9 transactions reported
Mixed
9 txns
Insider
Weitkamp Robin Joseph
Role
VP and GM Surfactants-INT
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Stock Appreciation Right | -- | -- | -- |
| holding | Performance Shares | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Stock Appreciation Right | -- | -- | -- |
| holding | Performance Shares | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Stock Appreciation Right | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Restricted Stock Units — 2,614 contracts (Direct);
Stock Appreciation Right — 5,044 contracts (Direct);
Performance Shares — 1,375 contracts (Direct);
Common Stock — 96.9 shares (Indirect, By ESOP II Trust)
Footnotes (6)
- F1. Vests ratably over three years beginning on the date shown.
- F2. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Stepan Company common stock.
- F3. The performance shares vest upon the certification of Stepan Company achieving certain performance goals for the performance period ending December 31, 2027.
- F4. Each performance share represents a contingent right to receive one share of Stepan Company common stock.
- F5. The performance shares vest upon the certification of Stepan Company achieving certain performance goals for the performance period ending December 31, 2028.
- F6. The performance shares vest upon the certification of Stepan Company achieving certain performance goals for the performance period ending December 31, 2028.
Key Figures
RSUs grant: 280 RSUs
RSUs grant: 836 RSUs
RSUs grant: 1,498 RSUs
+5 more
8 metrics
RSUs grant
280 RSUs
Contingent right to 280 Stepan common shares
RSUs grant
836 RSUs
Time-based vesting award
RSUs grant
1,498 RSUs
Time-based vesting award
Stock appreciation rights
1,128 underlying shares at $89.53
SAR on Stepan common stock, long-dated expiry
Stock appreciation rights
1,769 underlying shares at $59.86
SAR on Stepan common stock, expiring 2035-03-02
Stock appreciation rights
2,147 underlying shares at $50.06
SAR on Stepan common stock, expiring 2036-03-01
Performance shares
626 performance shares
Contingent on goals through 2027 period
Indirect common stock holding
96.9 shares
Common stock held by ESOP II Trust
Key Terms
Restricted Stock Units, Performance Shares, Stock Appreciation Right, ESOP II Trust, +1 more
5 terms
Restricted Stock Units financial
"Each restricted stock unit ("RSU") represents a contingent right to receive one share of Stepan Company common stock."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Stock Appreciation Right financial
"Stock Appreciation Right with underlying Stepan common stock and stated exercise prices."
A stock appreciation right (SAR) is a form of employee pay that gives the holder the right to receive the increase in a company's share price over a set reference price, paid in cash or shares, without having to buy stock first. It matters to investors because SARs can create future cash outflows or dilute existing shareholders if settled in stock, and they align employee incentives with share-price performance like a bonus tied to a home's price rise.
ESOP II Trust financial
"Common Stock ownership of 96.9000 shares reported as indirect, "By ESOP II Trust"."
vests ratably over three years financial
"Vests ratably over three years beginning on the date shown."
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Stepan (SCL) Form 3 filing by Robin Joseph Weitkamp show?
The Form 3 shows initial equity holdings for executive Robin Joseph Weitkamp. It lists restricted stock units, stock appreciation rights, performance shares, and an indirect ESOP II Trust position, all representing potential future Stepan common stock ownership.
What restricted stock units does Robin Joseph Weitkamp hold in Stepan (SCL)?
Robin Joseph Weitkamp holds several restricted stock unit awards, including positions representing 280, 836 and 1,498 units. Each RSU represents a contingent right to receive one share of Stepan Company common stock, typically vesting ratably over three years from the grant date.
What are the stock appreciation rights disclosed for Stepan (SCL) executive Robin Weitkamp?
The filing lists stock appreciation rights tied to 1,128 underlying shares at an exercise price of $89.53 and 1,769 and 2,147 underlying shares at exercise prices of $59.86 and $50.06. These rights are linked to Stepan common stock and have long-dated expiration terms.
What indirect Stepan (SCL) holdings are reported for Robin Joseph Weitkamp?
The Form 3 reports an indirect holding of 96.9 shares of Stepan common stock held "By ESOP II Trust." This indicates part of the executive’s exposure to Stepan equity is through a trust structure rather than directly owned shares.
Does the Stepan (SCL) Form 3 indicate any recent insider buying or selling?
The Form 3 primarily lists holdings and award details rather than explicit buys or sells. Transaction codes are marked as unknown, and the summary data show no categorized buy or sell transactions, focusing instead on existing equity-based positions.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates